Advertisement
Skip to Content

MediciNova Inc MNOV Stock Quote

| Rating as of

NASDAQ: MNOV

Last close prices updated as of Feb 08, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 2.36
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Value
  • Day Range 2.36  –  2.39
  • Year Range 1.95  –  3.18
  • Market Cap 115.7491 Mil
  • Volume / Avg 20,284.0 /  94,108.1
  • Price / Sales 2,824.32
  • Price / Book 1.58
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis MNOV

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics MNOV

Company Profile MNOV

Business Description

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of the small molecule therapeutics segments.

Contact
4275 Executive Square, Suite 300
La Jolla, CA, 92037
Industry Biotechnology
Employees 11

FAQs for MediciNova Inc Stock

No. MNOV does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

MNOV’s market cap is 115.75 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

MNOV’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

MNOV’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare MNOV’s historical performance against its industry peers and the overall market.